Introduction to nosocomial infections, their definition, prevalence in healthcare settings, common types of nosocomial infections, and the impact on patients and healthcare facilities.
Understanding Nosocomial (Hospital‑Acquired) Infections
Prepared as concise, study‑ready notes
1. Definition & Scope
| Term |
Meaning |
| Nosocomial infection (NI) |
An infection that develops ≥48 h after hospital admission or within 30 days after discharge (or up to 1 year after an implant) and was not present or incubating at the time of admission. |
| Healthcare‑Associated Infection (HAI) |
Modern, broader term that includes infections acquired in any health‑care setting (hospital, long‑term care, dialysis, outpatient clinics). |
| Incidence |
~5–10 % of hospitalized patients in high‑income countries; higher in ICUs (10–20 %). |
| Impact |
↑ morbidity, mortality, length of stay, and health‑care costs (≈ $30–$45 billion/yr in the U.S.). |
2. Common Types of Nosocomial Infections
| Infection |
Typical Pathogens |
Key Clinical Features |
| Urinary Tract Infection (UTI) |
E. coli, Klebsiella, Enterococcus, Pseudomonas |
Dysuria, flank pain, fever; often catheter‑associated. |
| Surgical Site Infection (SSI) |
Staphylococcus aureus (including MRSA), Streptococcus, Enterobacteriaceae |
Redness, purulent drainage, wound dehiscence; can be superficial or deep. |
| Bloodstream Infection (BSI) / Central Line‑Associated BSI (CLABSI) |
Coagulase‑negative Staphylococci, S. aureus, Candida, Gram‑negative rods |
Fever, chills, hypotension; source often intravascular catheters. |
| Pneumonia (Ventilator‑Associated Pneumonia, VAP) |
Pseudomonas aeruginosa, Acinetobacter, MRSA, Enterobacteriaceae |
New infiltrate on CXR + fever, purulent sputum, worsening oxygenation. |
| Clostridioides difficile infection (CDI) |
C. difficile (toxin‑producing strains) |
Watery diarrhea, abdominal cramping; often after broad‑spectrum antibiotics. |
| Other |
Mycobacterium tuberculosis (nosocomial TB), fungal infections (e.g., Candida, Aspergillus) |
Occur in immunocompromised hosts or after prolonged antimicrobial use. |
3. Pathogenesis & Risk Factors
3.1. Mechanisms
- Endogenous flora – patient’s own microbes translocate (e.g., gut → bloodstream).
- Exogenous sources – contaminated devices, hands of health‑care workers, environment.
- Biofilm formation – on catheters, prosthetic devices, endotracheal tubes → protects microbes from antibiotics and host defenses.
3.2. Patient‑Related Risk Factors
| Category |
Examples |
| Age |
Neonates, elderly |
| Comorbidities |
Diabetes, chronic lung disease, renal failure |
| Immune status |
Chemotherapy, steroids, HIV |
| Invasive devices |
Urinary catheters, central lines, endotracheal tubes |
| Surgical procedures |
Large incisions, prosthetic implants |
| Antibiotic exposure |
Broad‑spectrum |